Olpha, the subsidiary of JSC AB City, is one of the largest companies in the Baltic states with more than 50 years of experience in the production of medicines and chemical pharmaceutical products. Portfolio contains over 60 FDFs, 25 APIs and more than 25 Intermediates. The key areas of specialization in FDFs include neurology, cardiology, infectology and allergology. Olainfarm has a long-standing technological and know-how advantage in adamantane, quinuclidine and nitrofurane chemistry. Olpha Group includes a network of medical and pharmaceutical enterprises specialising in their own discipline, covering a wide range of areas - supplement manufacturers Silvanols, RFF and Jonax. Olainfarm is certified in accordance with the requirements of the EU GMP for APIs and FDFs, the U.S. cGMP for certain APIs (FDA), TGA for FDFs (Australia), CEP for certain APIs, ISO 14001 Environmental Management System and ISO 17025 Laboratory Management System. Visit http://www.olpha.eu/ for more information. Current vacancies: https://olpha.eu/en/careers
| Website | http://www.olpha.eu |
| Revenue | $6.3 million |
| Employees | 361 (227 on RocketReach) |
| Founded | 1972 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Pharmaceutical Manufacturing, Medicine Production, Api Manufacturing, Drug Manufacturing, Pharmaceutical Api, Active Pharmaceutical Ingredients, Finished Dosage Forms, Drug Development, Pharmaceutical Production, Healthcare, Biopharma, Drug Substance, Pharmaceutical Ingredients, Drug Products, Prescription Drugs, Over The Counter Drugs |
| Competitors | Lockheed Martin, Boeing, Northrop Grumman, BAE Systems, Thales, Raytheon Co., General Dynamics, Elbit Systems Ltd, AgustaWestland, Alion Science and Technology +41 more (view full list) |
Looking for a particular Olpha Global employee's phone or email?
The Olpha Global annual revenue was $6.3 million in 2026.
Alexey Cherchago is the Chief Operating Officer at European Markets of Olpha Global.
227 people are employed at Olpha Global.